Definition for the Assessment of Time-to-event Endpoints in CANcer Trials (DATECAN-1)
Definition for the Assessment of Time-to-event Endpoints in CANcer Trials (DATECAN-1)
Active, not recruiting · NCT03676010 · Registry updated 2025-12-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Definition for the Assessment of Time-to-event Endpoints in CANcer Trials (DATECAN-1) | cancer, neoplasm | Active, not recruiting | Not stated | 2025-12-10 | NCT03676010 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Centre Georges Francois Leclerc | 28 |
| Institut Bergonié | 27 |
| Institut du Cancer de Montpellier - Val d'Aurelle | 67 |
| National Cancer Institute, France | 61 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Georges François Leclerc | Dijon | France | 35 |
| Institut Bergonié | Bordeaux | France | 53 |
| Institut du Cancer de Montpellier | Montpellier | France | 7 |